Affiliation:
1. UPMC Hillman Cancer Center Pittsburgh Pennsylvania USA
2. Department of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA
Abstract
This commentary highlights the key, recent advances made in the field of melanoma. Although significant gains have been made, particularly for resectable disease, ongoing challenges remain in the PD1‐refractory setting.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献